M. Arfan Ikram

131.3k total citations · 14 hit papers
837 papers, 34.1k citations indexed

About

M. Arfan Ikram is a scholar working on Psychiatry and Mental health, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M. Arfan Ikram has authored 837 papers receiving a total of 34.1k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Psychiatry and Mental health, 155 papers in Physiology and 151 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M. Arfan Ikram's work include Dementia and Cognitive Impairment Research (135 papers), Cerebrovascular and Carotid Artery Diseases (74 papers) and Alzheimer's disease research and treatments (62 papers). M. Arfan Ikram is often cited by papers focused on Dementia and Cognitive Impairment Research (135 papers), Cerebrovascular and Carotid Artery Diseases (74 papers) and Alzheimer's disease research and treatments (62 papers). M. Arfan Ikram collaborates with scholars based in Netherlands, United States and United Kingdom. M. Arfan Ikram's co-authors include Albert Hofman, Meike W. Vernooij, Aad van der Lugt, Monique M.B. Breteler, Peter J. Koudstaal, Wiro J. Niessen, Oscar H. Franco, Frank J. Wolters, Gabriël P. Krestin and M. Kamran Ikram and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

M. Arfan Ikram

798 papers receiving 33.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidental Findings on Brain MRI in the General Population

2007 1.1k citations Meike W. Vernooij, M. Arfan Ikram et al. profile →
Prevalence and risk factors of cerebral microbleeds

2008 613 citations Meike W. Vernooij, M. Arfan Ikram et al. Neurology profile →
The changing prevalence and incidence of dementia over time — current evidence

2017 482 citations M. Arfan Ikram et al. profile →
Cerebral Perfusion and the Risk of Dementia

2017 359 citations Frank J. Wolters, Hazel I. Zonneveld et al. profile →
Objectives, design and main findings until 2020 from the Rotterdam Study

2020 316 citations M. Arfan Ikram, Guy Brusselle et al. European Journal of Epidemiology profile →
The Rotterdam Study: 2018 update on objectives, design and main results

2017 312 citations M. Arfan Ikram, Guy Brusselle et al. European Journal of Epidemiology profile →
Association of Adherence to a Healthy Diet with Cognitive Decline in European and American Older Adults: A Meta-Analysis within the CHANCES Consortium

2017 306 citations Jessica C. Kiefte–de Jong, Oscar H. Franco et al. profile →
The Rotterdam Study: 2016 objectives and design update

2015 295 citations Guy Brusselle, Cornelia M. van Duijn et al. European Journal of Epidemiology profile →
Social brain, social dysfunction and social withdrawal

2018 256 citations M. Arfan Ikram et al. profile →
Gut microbiome-wide association study of depressive symptoms

2022 252 citations André G. Uitterlinden, M. Arfan Ikram et al. profile →
Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study

2020 215 citations Silvan Licher, Sanaz Sedaghat et al. profile →
Association of Insulin Resistance and Type 2 Diabetes With Gut Microbial Diversity

2021 210 citations Maryam Kavousi, M. Arfan Ikram et al. profile →
Sarcopenia and Sarcopenic Obesity and Mortality Among Older People

2024 100 citations Elizabeth Benz, Fernando Rivadeneira et al. profile →
The Rotterdam Study. Design update and major findings between 2020 and 2024

2024 54 citations M. Arfan Ikram, Brenda C.T. Kieboom et al. European Journal of Epidemiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Arfan Ikram Netherlands	96	6.5k	6.4k	5.7k	5.6k	4.8k	837	34.1k
Sudha Seshadri United States	94	6.9k 1.1×	7.6k 1.2×	3.0k 0.5×	4.4k 0.8×	7.0k 1.5×	481	31.0k
Alexa Beiser United States	101	6.9k 1.1×	6.6k 1.0×	3.0k 0.5×	5.6k 1.0×	11.4k 2.4×	367	37.5k
Charles DeCarli United States	90	9.5k 1.5×	6.6k 1.0×	3.1k 0.5×	2.8k 0.5×	3.3k 0.7×	447	23.9k
Lenore J. Launer United States	111	13.2k 2.0×	13.0k 2.0×	5.8k 1.0×	4.4k 0.8×	7.5k 1.6×	612	43.4k
Christopher Chen Singapore	69	5.1k 0.8×	5.7k 0.9×	3.1k 0.5×	4.1k 0.7×	2.6k 0.5×	617	23.2k
Eric E. Smith Canada	96	5.2k 0.8×	4.1k 0.6×	10.8k 1.9×	16.2k 2.9×	4.7k 1.0×	646	32.0k
Peter J. Koudstaal Netherlands	96	6.2k 1.0×	4.4k 0.7×	8.3k 1.4×	12.5k 2.2×	11.7k 2.4×	448	38.8k
Christophe Tzourio France	80	5.6k 0.9×	3.7k 0.6×	4.5k 0.8×	3.0k 0.5×	4.5k 0.9×	393	21.3k
Walter J. Koroshetz United States	83	9.5k 1.5×	6.8k 1.1×	8.0k 1.4×	9.8k 1.8×	1.8k 0.4×	224	33.9k
Martin Dichgans Germany	86	5.0k 0.8×	3.3k 0.5×	10.6k 1.8×	5.9k 1.1×	2.7k 0.6×	420	28.5k

Countries citing papers authored by M. Arfan Ikram

Since Specialization

Citations

This map shows the geographic impact of M. Arfan Ikram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Arfan Ikram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Arfan Ikram more than expected).

Fields of papers citing papers by M. Arfan Ikram

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Arfan Ikram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Arfan Ikram. The network helps show where M. Arfan Ikram may publish in the future.

Co-authorship network of co-authors of M. Arfan Ikram

This figure shows the co-authorship network connecting the top 25 collaborators of M. Arfan Ikram. A scholar is included among the top collaborators of M. Arfan Ikram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Arfan Ikram. M. Arfan Ikram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kieboom, Brenda C.T., et al.. (2024). Healthcare avoidance during the early stages of the COVID-19 pandemic and all-cause mortality: a longitudinal community-based study. British Journal of General Practice. 74(748). e791–e796.

Verberk, Inge M.W., Charlotte E. Teunissen, Astrid C. J. Nooyens, et al.. (2024). Depressive Symptoms and Plasma Markers of Alzheimer's Disease and Neurodegeneration: A Coordinated Meta-Analysis of 8 Cohort Studies. American Journal of Geriatric Psychiatry. 32(9). 1141–1153. 3 indexed citations

Suganthi, A., et al.. (2024). Role of Lactic Acid Bacteria in Insecticide Residue Degradation. Probiotics and Antimicrobial Proteins. 17(1). 81–102. 3 indexed citations

Hofman, Amy, Trudy Voortman, M. Arfan Ikram, & Annemarie I. Luik. (2021). Substitutions of physical activity, sedentary behaviour and sleep: associations with mental health in middle-aged and elderly persons. Journal of Epidemiology & Community Health. 76(2). 175–181. 28 indexed citations

Wijnant, Sara, Silvan Licher, Natalie Terzikhan, et al.. (2021). Lung Function Impairment and the Risk of Incident Dementia: The Rotterdam Study. Journal of Alzheimer s Disease. 82(2). 621–630. 20 indexed citations

Benz, Elizabeth, Sara Wijnant, Katerina Trajanoska, et al.. (2021). Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma: a population-based study. ERJ Open Research. 8(1). 628–2021. 42 indexed citations

Lysen, Thom S., Annemarie I. Luik, M. Kamran Ikram, et al.. (2020). Actigraphy‐estimated sleep and 24‐hour activity rhythms and the risk of dementia. Alzheimer s & Dementia. 16(9). 1259–1267. 53 indexed citations

Sørensen, Lauge, Frank J. Wolters, Wiro J. Niessen, et al.. (2019). The value of hippocampal volume, shape, and texture for 11-year prediction of dementia: a population-based study. Neurobiology of Aging. 81. 58–66. 10 indexed citations

Licher, Silvan, Shahzad Ahmad, Hata Karamujić‐Čomić, et al.. (2019). Genetic predisposition, modifiable-risk-factor profile and long-term dementia risk in the general population. Nature Medicine. 25(9). 1364–1369. 146 indexed citations

10.

Fani, Lana, Saima Hilal, Sanaz Sedaghat, et al.. (2019). Telomere Length and the Risk of Alzheimer’s Disease: The Rotterdam Study. Journal of Alzheimer s Disease. 73(2). 707–714. 47 indexed citations

11.

Yang, Yuanhao, Huiying Zhao, Dorret I. Boomsma, et al.. (2018). Molecular genetic overlap between migraine and major depressive disorder. European Journal of Human Genetics. 26(8). 1202–1216. 54 indexed citations

12.

Licher, Silvan, Sirwan K.L. Darweesh, Frank J. Wolters, et al.. (2018). Lifetime risk of common neurological diseases in the elderly population. Journal of Neurology Neurosurgery & Psychiatry. 90(2). 148–156. 55 indexed citations

13.

Kieboom, Brenda C.T., Robert Zietse, M. Arfan Ikram, Ewout J. Hoorn, & Bruno H. Stricker. (2018). Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population. Pharmacoepidemiology and Drug Safety. 27(11). 1166–1173. 33 indexed citations

14.

Voortman, Trudy, Jessica C. Kiefte–de Jong, M. Arfan Ikram, et al.. (2017). Adherence to the 2015 Dutch dietary guidelines and risk of non-communicable diseases and mortality in the Rotterdam Study. European Journal of Epidemiology. 32(11). 993–1005. 116 indexed citations

15.

Wen, Kexin, Ünal Mutlu, M. Kamran Ikram, et al.. (2017). The retinal microcirculation in migraine: The Rotterdam Study. Cephalalgia. 38(4). 736–743. 5 indexed citations

16.

Hanewinckel, Rens, Judith Drenthen, Vincentius J.A. Verlinden, et al.. (2017). Polyneuropathy relates to impairment in daily activities, worse gait, and fall-related injuries. Neurology. 89(1). 76–83. 23 indexed citations

17.

Glišić, Marija, Blerim Mujaj, Oscar L. Rueda‐Ochoa, et al.. (2017). Associations of Endogenous Estradiol and Testosterone Levels With Plaque Composition and Risk of Stroke in Subjects With Carotid Atherosclerosis. Circulation Research. 122(1). 97–105. 39 indexed citations

18.

Ikram, M. Arfan, Hazel I. Zonneveld, Gennady V. Roshchupkin, et al.. (2017). Heritability and genome-wide associations studies of cerebral blood flow in the general population. Journal of Cerebral Blood Flow & Metabolism. 38(9). 1598–1608. 11 indexed citations

19.

Roshchupkin, Gennady V., Hieab H.H. Adams, Meike W. Vernooij, et al.. (2016). HASE: Framework for efficient high-dimensional association analyses. Scientific Reports. 6(1). 15 indexed citations

20.

Mutlu, Ünal, M. Arfan Ikram, Albert Hofman, et al.. (2016). N-Terminal Pro-B–Type Natriuretic Peptide Is Related to Retinal Microvascular Damage. Arteriosclerosis Thrombosis and Vascular Biology. 36(8). 1698–1702. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact